2017
DOI: 10.1165/rcmb.2016-0321oc
|View full text |Cite
|
Sign up to set email alerts
|

A Novel In Vitro Human Granuloma Model of Sarcoidosis and Latent Tuberculosis Infection

Abstract: Many aspects of pathogenic granuloma formation are poorly understood, requiring new relevant laboratory models that represent the complexity (genetics and diversity) of human disease. To address this need, we developed an in vitro model of granuloma formation using human peripheral blood mononuclear cells (PBMCs) derived from patients with active sarcoidosis, latent tuberculosis (TB) infection (LTBI), or normal healthy control subjects. PBMCs were incubated for 7 days with uncoated polystyrene beads or beads c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
80
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
4
1
1

Relationship

0
6

Authors

Journals

citations
Cited by 57 publications
(85 citation statements)
references
References 54 publications
2
80
0
3
Order By: Relevance
“…Newly developed in vitro human granuloma models could help further establish the mechanisms of macrophage polarization during early granuloma formation, maturation, and disintegration of the structures during reactivation of the disease . Confirming similar observations, PBMCs isolated from cohorts of bacillus Calmette‐Guérin (BCG)‐vaccinated individuals, and individuals with LTBI, patients with active TB, and people from contact investigations following recent TB exposure, showed a variable capacity to control mycobacterial growth .…”
Section: Macrophage Heterogeneity and M Tuberculosis Infectionmentioning
confidence: 58%
“…Newly developed in vitro human granuloma models could help further establish the mechanisms of macrophage polarization during early granuloma formation, maturation, and disintegration of the structures during reactivation of the disease . Confirming similar observations, PBMCs isolated from cohorts of bacillus Calmette‐Guérin (BCG)‐vaccinated individuals, and individuals with LTBI, patients with active TB, and people from contact investigations following recent TB exposure, showed a variable capacity to control mycobacterial growth .…”
Section: Macrophage Heterogeneity and M Tuberculosis Infectionmentioning
confidence: 58%
“…To validate the successful establishment of a microscale in vitro granuloma model within our platform, we used three separate previously reported readouts: 1) aggregate formation, 2) encapsulation of the mycobacterium within host immune cells, and 3) soluble factor analysis. (Birkness et al 2007; Kapoor et al 2013; Crouser et al 2017; Tezera et al 2017) After initiating infection by mixing MDMs and BCG into the ECM (collagen I) and seeding it into the wells, we consistently observed aggregate formation in the granuloma layer containing BCG when wells were fixed and imaged on Day 4 post infection (p.i.) (Figure 2).…”
Section: Resultsmentioning
confidence: 87%
“…(Yu et al 2019) The first layer, herein called the granuloma layer, consists of an infection model of monocyte-derived macrophages (MDMs) and a model mycobacterium strain, Mycobacterium bovis Bacillus Calmette-Guérin (BCG), suspended in a 3D extracellular matrix (ECM) plug to mimic some aspects of in vivo granuloma behavior (e.g., pathogen encapsulation, soluble factor secretion, aggregate formation) previously observed in other in vitro granuloma models. (Birkness et al 2007; Kapoor et al 2013; Crouser et al 2017) The second layer, herein called the endothelial layer, consists of an in vitro angiogenesis model in which endothelial cells are cultured on a hydrogel plug. By placing the primary human endothelial cells on a separate Stacks layer, our model can be used to examine the induction of angiogenic processes around the granuloma layer and how those angiogenic processes are affected by the soluble factor signaling profile of the granuloma layer.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations